Broach Lifecare Hospital Share Price
15.50+0.00 (+0.00%)
-25.84% past 1 Year
Corporate filings & documents
Announcements
With reference to the email received on September 11 2026 we hereby enclosing fresh corporate Announcement regarding Resignation of Chief Financial Officer of the Company.
1 week agoWith reference to the email received on September 11 2026 we hereby enclosing fresh corporate Announcement regarding Resignation of Chief Financial Officer of the Company.
1 week agoWe hereby enclose the letter sent to the shareholders whose email addresses are not registered with the company.
1 week agoWe hereby enclose the letter sent to the shareholders whose email addresses are not registered with the company.
1 week agoWe hereby enclose the copy of Newspaper publication for the upcoming Annual General Meeting.
1 week agoWe hereby enclose the copy of Newspaper publication for the upcoming Annual General Meeting.
1 week agoIntimation regarding Annual Report for Financial Year 2025-26 under Regulation 34 of the SEBI (LODR) Regulation 2015.
1 week agoIntimation regarding Annual Report for Financial Year 2025-26 under Regulation 34 of the SEBI (LODR) Regulation 2015.
1 week agoBROACH LIFECARE HOSPITAL LIMITED has informed the Exchange regarding the Notice of the Annual General Meeting to be held on September 30 2026
1 week agoBROACH LIFECARE HOSPITAL LIMITED has informed the Exchange regarding the Notice of the Annual General Meeting to be held on September 30 2026
1 week agoWe wish to inform you that the Board in its meeting held on September 05 2026 has appointed M/s Rahul S. Mithaiwala & Co. as a Secretrial Auditor of the company for 5 years subject to the approval of members.
2 weeks agoWe wish to inform you that the Board in its meeting held on September 05 2026 has appointed M/s Rahul S. Mithaiwala & Co. as a Secretrial Auditor of the company for 5 years subject to the approval of members.
2 weeks agoThe Board of Directors of the Company at their Meeting held today i.e. Saturday September 5 2026 inter-alia approved the Directors Report for FY 2025-26; approved the appointment of M/s. RAHUL S. MITHAIWALA & CO. as Secretarial Auditor for 5 years subject to members approval; fixed September 30 2026 at 11:30 A.M. (IST) for the AGM through VC/OAVM and approved the Notice thereof; fixed September 23 2026 as the cut-off date for e-Voting; approved NSDL as the e-Voting agency; and appointed M/s. RAHUL S. MITHAIWALA & CO. as Scrutinizer for the e-Voting process.
2 weeks agoThe Board of Directors of the Company at their Meeting held today i.e. Saturday September 5 2026 inter-alia approved the Directors Report for FY 2025-26; approved the appointment of M/s. RAHUL S. MITHAIWALA & CO. as Secretarial Auditor for 5 years subject to members approval; fixed September 30 2026 at 11:30 A.M. (IST) for the AGM through VC/OAVM and approved the Notice thereof; fixed September 23 2026 as the cut-off date for e-Voting; approved NSDL as the e-Voting agency; and appointed M/s. RAHUL S. MITHAIWALA & CO. as Scrutinizer for the e-Voting process.
2 weeks agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair. 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair.
2 weeks agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair. 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair.
2 weeks agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair.
2 weeks agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve 1. Approval of the date time venue and notice of the ensuing AGM.2. Any other matter with the permission of the Chair.
2 weeks agoPlease find the attached intimation regarding resignation of company secretary and compliance office and disclosure under Regulation-30 of SEBI (LODR) Regulation 2015
2 weeks agoPlease find the attached intimation regarding resignation of company secretary and compliance office and disclosure under Regulation-30 of SEBI (LODR) Regulation 2015
2 weeks agoWe wish to inform you that the Board of Directors has appointed M/s. Rahul S. Mithaiwala & Co. as Secretarial Auditor of the Company for FY 2025-26.
3 weeks agoWe wish to inform you that the Board of Directors has appointed M/s. Rahul S. Mithaiwala & Co. as Secretarial Auditor of the Company for FY 2025-26.
3 weeks agoWe are enclosing herewith Outcome of Board Meeting held on August 26 2026.
3 weeks agoWe are enclosing herewith Outcome of Board Meeting held on August 26 2026.
3 weeks agoWe hereby inform you that the Company has received resignation letter dated August 24 2026 from Ms. Urvi Mrunal Hindia from the position of CFO of the Company.
3 weeks agoWe hereby inform you that the Company has received resignation letter dated August 24 2026 from Ms. Urvi Mrunal Hindia from the position of CFO of the Company.
3 weeks agoWe are enclosing herewith disclosure relating to the resignation of Secretarial Auditor M/s. N R Shah & Co. Secretarial Auditor of the Company w.e.f August 13 2026.
3 weeks agoWe are enclosing herewith disclosure relating to the resignation of Secretarial Auditor M/s. N R Shah & Co. Secretarial Auditor of the Company w.e.f August 13 2026.
3 weeks agoPlease find attached herewith the certificate under Reg 74(5) for the Quarter ended June 30 2026.
3 weeks agoPlease find attached herewith the certificate under Reg 74(5) for the Quarter ended June 30 2026.
3 weeks agoThe Company has received Permanent Certificate for Registration of Clinical Establishment from concerned authority for its Hospital at Bharuch.Consequent to the aforesaid approval the bed capacity of the Bharuch Hospital has increased from 25 beds to 50 beds. Accordingly overall bed capacity of Company has increased from 40 beds to 65 beds.
3 months agoThe Company has received Permanent Certificate for Registration of Clinical Establishment from concerned authority for its Hospital at Bharuch.Consequent to the aforesaid approval the bed capacity of the Bharuch Hospital has increased from 25 beds to 50 beds. Accordingly overall bed capacity of Company has increased from 40 beds to 65 beds.
3 months agoThe Company has received permanent Certificate for Registration of Clinical Establishment from Government of Gujarat Health and Family Welfare Department for 50 bed Capacity at Hospital located at Bharuch Gujarat
3 months agoThe Company has received permanent Certificate for Registration of Clinical Establishment from Government of Gujarat Health and Family Welfare Department for 50 bed Capacity at Hospital located at Bharuch Gujarat
3 months agoPursuant to Reg 30 of SEBI(LODR) Regulations 2015 we hereby submit duly signed audited standalone financial results for the half year and financial year ended on March 31 2026 along with Auditors report under reg. 33 of SEBI (LODR) Regulations 2015.
4 months agoStatement of Deviations and variations of funds raised through public issue (IPO) under Reg 32(1) if SEBI (LODR) Regulations 2015 as on March 31 2026 pursuant to allotment of equity shares on public issue (IPO).
4 months agoStatement of Deviations and variations of funds raised through public issue (IPO) under Reg 32(1) if SEBI (LODR) Regulations 2015 as on March 31 2026 pursuant to allotment of equity shares on public issue (IPO).
4 months agoAudited Standalone Financial Results of the company for the half year and year ended on March 31 2026 along with Auditors Report under Reg 33 of SEBI (LODR) Regulations 2015.
4 months agoAudited Standalone Financial Results of the company for the half year and year ended on March 31 2026 along with Auditors Report under Reg 33 of SEBI (LODR) Regulations 2015.
4 months agoWe hereby inform that Board of Directors of company at its meeting held today i.e. May 21 2026 inter alia have considered approved and taken on record inter-alia the following businesses:1. Audited Standalone Financial Results of the Company for the Half Year and Year ended March 31 2026 in terms of Regulation 33 of the Listing Obligations;2. Considered and approved other business matters as per the Agenda including any Other Business matters with the approval of the Chairman.A copy of the Audited Standalone Financial Results of the Company for the Half-Year and Year ended March 31 2026 along with the Auditors Report declaration with respect to the Audit Report with unmodified opinion on the Audited Standalone Financial Results Statement of deviation(s) and variation(s) Certificate of Correctness of financial results have been enclosed herewith. Kindly note that the meeting of the Board of Directors of the Company commenced at 04.00 p.m. and concluded at 06.15 pm.
4 months agoWe hereby inform that Board of Directors of company at its meeting held today i.e. May 21 2026 inter alia have considered approved and taken on record inter-alia the following businesses:1. Audited Standalone Financial Results of the Company for the Half Year and Year ended March 31 2026 in terms of Regulation 33 of the Listing Obligations;2. Considered and approved other business matters as per the Agenda including any Other Business matters with the approval of the Chairman.A copy of the Audited Standalone Financial Results of the Company for the Half-Year and Year ended March 31 2026 along with the Auditors Report declaration with respect to the Audit Report with unmodified opinion on the Audited Standalone Financial Results Statement of deviation(s) and variation(s) Certificate of Correctness of financial results have been enclosed herewith. Kindly note that the meeting of the Board of Directors of the Company commenced at 04.00 p.m. and concluded at 06.15 pm.
4 months agoBroach Lifecare Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve the meeting of the Board of Directors of BROACH LIFECARE HOSPITAL LIMITED (the Company) is scheduled to be held on Thursday May 21 2026 at 04.00 p.m. at the registered office situated at 501 5TH FLOOR CORPORATE HOUSE ABOVE BHARUCH ORTHOPAEDIC HOSPITAL R K CASTA BHARUCH-392001 GUJARAT INDIA to inter alia transact following business:1. To receive consider and approve the audited financial results for the half year and year ended on 31st March 2026 2. Other Business Agenda3. Any other business with permission of ChairpersonAs intimated to you vide letter dated March 28 2026 the trading window for dealing in shares of the Company by the designated persons is already closed since April 01 2026 until 48 hours of the declaration of financial results for the half year and year ended on March 31 2026.
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Broach Lifecare Hospital Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L86100GJ2023PLC140499</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SWATI SHARMA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: URVI MRUNAL HINDIA <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Broach Lifecare Hospital Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L86100GJ2023PLC140499</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: SWATI SHARMA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: URVI MRUNAL HINDIA <br/> Designation: CFO <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoCertificate under regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on March 31 2026 received from Kfin Technologies Limited Registrar and Transfer Agent of the Company.
5 months agoCertificate under regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on March 31 2026 received from Kfin Technologies Limited Registrar and Transfer Agent of the Company.
5 months agoThe trading window for dealing in securities of the Company shall be closed for all designated persons including Directors and promoters designated employees and their immediate relatives from April 01 2026 till completion of 48 hours after the declaration of Standalone audited financial results for half year and financial year ending on March 31 2026. Accordingly all designated persons designed employees and their immediate relatives are advised not to trade in the securities of the company during the aforesaid period of closure of trading window. This trading window closure notice operates independently and does not intend to amend alter modify curtail or extend any other notice on closure of trading window if any for any other purpose whether currently in effect or to be issued during the validity of this notice.
5 months agoThe trading window for dealing in securities of the Company shall be closed for all designated persons including Directors and promoters designated employees and their immediate relatives from April 01 2026 till completion of 48 hours after the declaration of Standalone audited financial results for half year and financial year ending on March 31 2026. Accordingly all designated persons designed employees and their immediate relatives are advised not to trade in the securities of the company during the aforesaid period of closure of trading window. This trading window closure notice operates independently and does not intend to amend alter modify curtail or extend any other notice on closure of trading window if any for any other purpose whether currently in effect or to be issued during the validity of this notice.
5 months agoCertificate under reg. 74(5) of SEBI (DP) Regulations 2018 for the Quarter Ended on December 31 2025.
6 months agoThe Company has approved the unaudited Standalone financial results for the half year ended on September 30 2025 along with the limited review report
10 months agoAnnual reports
Concalls & investor presentations
No presentations found